Search Tag: Frost & Sullivan

Executive Health Management


2014 13 May

Patent expiry, together with an increase in generic competition in the global pharmaceutical and biotechnology industry, is expected to bring a number of deals. According to newly released analysis from Frost & Sullivan entitled “Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry”, evolving conditions...Read more

Executive Health Management


2014 23 May

Hospitals across Eastern and Western Europe are responding to a growing demand for quality wound care and closure products by investing in high-technology solutions. The advanced wound care devices are more costly, but are reaching the market at a time when lifestyle diseases and longer life expectancy place a burden on hospitals to reduce bed occupancy....Read more